ENTITY
Alkem Laboratories

Alkem Laboratories (ALKEM IN)

103
Analysis
Health Care • India
Alkem Laboratories Ltd. is an Indian multinational pharmaceutical company specializing in generics and specialty pharmaceuticals. It manufactures and markets pharmaceutical generics, formulations, and nutraceuticals across India and global markets. The company's product portfolio also includes active pharmaceutical ingredients, branded products, vitamins, minerals, and nutritional products. Alkem Laboratories is headquartered in Mumbai, India, and was founded in 1973.
more
bullish•Alkem Laboratories
•04 Aug 2026 13:27

Primer: Alkem Laboratories Ltd (ALKEM IN) - Aug 2026

Alkem holds a dominant position in the Indian domestic formulations market, ranking fifth overall and leading in the anti-infective therapeutic...

Share
bearish•Mankind Pharma
•12 Dec 2023 08:34

Mankind Pharma Lock-Up - A US$1.1bn+ Lockup Release

The two pre-IPO investors have launched a block to sell around US$591m worth of Mankind Pharma shares. Since the lockup on the shares expired not...

Logo
934 Views
Share
•20 Sep 2026 08:30

APAC Healthcare Weekly (Sept 20) –Sino Bio, Impact Therapeutics, Takeda, Daiichi Sankyo, SK Biopharm

NMPA accepted Sino Bio’s NDA for bispecific ADC drug candidate. FDA granted priority review to Takeda’s zasocitinib for moderate-to-severe plaque...

Logo
92 Views
Share
bullish•Alkem Laboratories
•20 Feb 2026 10:47•Broker

Alkem Laboratories: Occlutech M&A to Support Medtech Aspiration. Maintain ADD

Alkem MedTech (a w.o.s of Alkem Labs) to acquire 51-55% stake in Occlutech Holding AG (Occlutech) for cash consideration of Euro 99.4 mn, implying...

Logo
218 Views
Share
•24 May 2026 08:30

APAC Healthcare Weekly (May 24)– Hansoh, Junshi Bio, Daiichi Sankyo, SanBio, Hanmi Pharm, Yuhan Corp

Hansoh’s HS-10504 tablets secured BTD in China. Junshi Bio secured 13th indication approval for toripalimab. Daiichi Sanyo’s Enhertu and Datroway...

Logo
132 Views
Share
x